HUE052077T2 - Tiszta 5-HT6 receptor antagonisták, acetilkolinészteráz inhibitorok és NMDA receptor antagonisták hármas kombinációja - Google Patents
Tiszta 5-HT6 receptor antagonisták, acetilkolinészteráz inhibitorok és NMDA receptor antagonisták hármas kombinációjaInfo
- Publication number
- HUE052077T2 HUE052077T2 HUE16763575A HUE16763575A HUE052077T2 HU E052077 T2 HUE052077 T2 HU E052077T2 HU E16763575 A HUE16763575 A HU E16763575A HU E16763575 A HUE16763575 A HU E16763575A HU E052077 T2 HUE052077 T2 HU E052077T2
- Authority
- HU
- Hungary
- Prior art keywords
- pure
- acetylcholinesterase inhibitors
- triple combination
- receptor antagonist
- receptor antagonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641017204 | 2016-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE052077T2 true HUE052077T2 (hu) | 2021-04-28 |
Family
ID=56896730
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE16763575A HUE052077T2 (hu) | 2016-05-18 | 2016-08-03 | Tiszta 5-HT6 receptor antagonisták, acetilkolinészteráz inhibitorok és NMDA receptor antagonisták hármas kombinációja |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US11253514B2 (hu) |
| EP (1) | EP3458039B1 (hu) |
| JP (1) | JP6629464B2 (hu) |
| KR (1) | KR102016120B1 (hu) |
| CN (1) | CN109152751A (hu) |
| AU (1) | AU2016407426B2 (hu) |
| BR (1) | BR112018073410A2 (hu) |
| CA (1) | CA3023836C (hu) |
| CY (1) | CY1123644T1 (hu) |
| DK (1) | DK3458039T3 (hu) |
| EA (1) | EA038087B1 (hu) |
| ES (1) | ES2815555T3 (hu) |
| HK (1) | HK1258022A1 (hu) |
| HR (1) | HRP20201412T1 (hu) |
| HU (1) | HUE052077T2 (hu) |
| IL (1) | IL262920B (hu) |
| LT (1) | LT3458039T (hu) |
| MA (1) | MA45002B1 (hu) |
| MD (1) | MD3458039T2 (hu) |
| MX (1) | MX2018014184A (hu) |
| NZ (1) | NZ747797A (hu) |
| PL (1) | PL3458039T3 (hu) |
| PT (1) | PT3458039T (hu) |
| RS (1) | RS60849B1 (hu) |
| SG (1) | SG11201809726UA (hu) |
| SI (1) | SI3458039T1 (hu) |
| WO (1) | WO2017199070A1 (hu) |
| ZA (1) | ZA201807310B (hu) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3648765A1 (en) * | 2017-07-03 | 2020-05-13 | Suven Life Sciences Limited | New uses of a pure 5-ht 6 receptor antagonist |
| AU2020396396A1 (en) * | 2019-12-02 | 2022-06-16 | Suven Life Sciences Limited | Methods for treating behavioral and psychological symptoms in patients with dementia |
| CA3162952A1 (en) | 2019-12-02 | 2021-06-10 | Suven Life Sciences Limited | Treating behavioral and psychological symptoms in dementia patients |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA04011762A (es) * | 2002-05-31 | 2005-03-31 | Lundbeck & Co As H | Una combinacion de antagonista de nmda e inhibidores de acetilcolinesterasa para el tratamiento de la enfermedad de alzheimer. |
| KR100818508B1 (ko) * | 2002-11-28 | 2008-03-31 | 수벤 라이프 사이언시스 리미티드 | 세로토닌 수용체 친화력을 가지는 엔-아릴술포닐-3-치환인돌, 그 제조방법 및 그를 포함하는 약제학적 조성물 |
| WO2011083487A1 (en) * | 2010-01-05 | 2011-07-14 | Suven Life Sciences Limited | Sulfone compounds as 5-ht6 receptor ligands |
| DK3077375T3 (en) | 2013-12-02 | 2017-09-11 | Suven Life Sciences Ltd | PROCEDURE FOR LARGE SCALE PREPARATION OF 1 - [(2-BROMPHENYL) SULPHONYL] -5-METHOXY-3 - [(4-METHYL-1-PIPERAZINYL) METHYL] -1H-INDOL-DIMESYLATE-MONOHYDRATE |
| WO2015158313A1 (en) * | 2014-04-19 | 2015-10-22 | Sunshine Lake Pharma Co., Ltd. | Sulfonamide derivatives and pharmaceutical applications thereof |
-
2016
- 2016-08-03 MA MA45002A patent/MA45002B1/fr unknown
- 2016-08-03 BR BR112018073410-1A patent/BR112018073410A2/pt not_active Application Discontinuation
- 2016-08-03 EP EP16763575.4A patent/EP3458039B1/en active Active
- 2016-08-03 SI SI201630909T patent/SI3458039T1/sl unknown
- 2016-08-03 MX MX2018014184A patent/MX2018014184A/es unknown
- 2016-08-03 AU AU2016407426A patent/AU2016407426B2/en active Active
- 2016-08-03 JP JP2018559327A patent/JP6629464B2/ja active Active
- 2016-08-03 RS RS20201045A patent/RS60849B1/sr unknown
- 2016-08-03 WO PCT/IB2016/054672 patent/WO2017199070A1/en unknown
- 2016-08-03 MD MDE20190349T patent/MD3458039T2/ro unknown
- 2016-08-03 DK DK16763575.4T patent/DK3458039T3/da active
- 2016-08-03 EA EA201892528A patent/EA038087B1/ru unknown
- 2016-08-03 CN CN201680085589.7A patent/CN109152751A/zh active Pending
- 2016-08-03 NZ NZ747797A patent/NZ747797A/en unknown
- 2016-08-03 LT LTEP16763575.4T patent/LT3458039T/lt unknown
- 2016-08-03 CA CA3023836A patent/CA3023836C/en active Active
- 2016-08-03 KR KR1020187035888A patent/KR102016120B1/ko active IP Right Grant
- 2016-08-03 HU HUE16763575A patent/HUE052077T2/hu unknown
- 2016-08-03 ES ES16763575T patent/ES2815555T3/es active Active
- 2016-08-03 SG SG11201809726UA patent/SG11201809726UA/en unknown
- 2016-08-03 PL PL16763575T patent/PL3458039T3/pl unknown
- 2016-08-03 PT PT167635754T patent/PT3458039T/pt unknown
- 2016-08-03 US US16/097,752 patent/US11253514B2/en active Active
-
2018
- 2018-10-31 ZA ZA2018/07310A patent/ZA201807310B/en unknown
- 2018-11-11 IL IL262920A patent/IL262920B/en active IP Right Grant
-
2019
- 2019-01-10 HK HK19100393.2A patent/HK1258022A1/zh unknown
-
2020
- 2020-09-03 HR HRP20201412TT patent/HRP20201412T1/hr unknown
- 2020-09-04 CY CY20201100834T patent/CY1123644T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL262921B (en) | Combination of pure 5-HT6 receptor antagonists with acetylcholinesterase inhibitors | |
| HK1258022A1 (zh) | 純5-ht6受體拮抗劑、乙醯膽鹼酯酶抑制劑和nmda受體拮抗劑的三重組合 | |
| SI3495352T1 (sl) | Kristalinične oblike antagonista androgenskih receptorjev, postopek njihove priprave in njihova uporaba | |
| HK1258023A1 (zh) | 純5-ht6受體拮抗劑與nmda受體拮抗劑的組合 | |
| IL271694A (en) | Novel uses of a pure 6HT–5 receptor antagonist | |
| HK1247105A1 (zh) | Mu類鴉片受體拮抗劑與類鴉片藥劑的組合劑型 | |
| HK1250163A1 (zh) | 作為5-氧代-ete受體拮抗劑的吲哚類似物及其使用方法 | |
| IL264405B (en) | Triple combination of histamine-3 receptor inverse agonists, acetylcholinesterase inhibitors and nmda receptor antagonist | |
| IL284081A (en) | Somatostatin receptor antagonistic compounds and methods of using them |